Page 1359 - Equine Clinical Medicine, Surgery and Reproduction, 2nd Edition
P. 1359

1334                                       CHAPTER 14



  VetBooks.ir  SEVERE COMBINED                            Management
           IMMUNODEFICIENCY
                                                          There is no specific treatment. Supportive therapy
           Definition/overview                            may extend life for a short period of time by treat-
                                                          ing opportunistic infections, but fatal infections are
           Severe combined immunodeficiency (SCID) is     inevitable. Genetic testing can detect carrier ani-
           most frequently seen in Arabians and occasionally   mals, which should be removed from the breeding
           Appaloosas. It is an inherited autosomal recessive   population.
           trait that results in failure to produce functional B
           and T lymphocytes.                             Prognosis
                                                          The prognosis is hopeless and euthanasia is indi-
           Aetiology/pathophysiology                      cated once the diagnosis has been confirmed.
           There is an  inherited 5-base-pair deletion  in the   The genetic and, therefore, future breeding,
           gene encoding a DNA protein kinase catalytic sub-  implications for the mare and stallion should be
           unit. When a foal is homozygous for this defect, it   considered.
           blocks the production of mature B and T lympho-
           cytes. Heterozygous carriers of the gene are clini-  FOAL IMMUNODEFICIENCY SYNDROME
           cally normal.                                  (PREVIOUSLY FELL PONY SYNDROME)
             Affected foals with effective transfer of colos-
           tral immunity are usually healthy for the first 1–3  Definition/overview
           months of life. When the level of maternally derived   A fatal immunodeficiency syndrome affecting Fell
           antibody start to fall, the foal is unable to produce   and Dales pony foals. The syndrome is characterized
           endogenous antibody and cell-mediated immune   by severe anaemia and lymphopenia. The syndrome
           responses, and succumbs to recurrent infections.  is caused by a mutation on chromosome ECA26 with
                                                          autosomal recessive inheritance.
           Clinical presentation                            Affected foals are healthy at birth, but usually
           Affected foals are  normal at birth and then suf-  present at 1–16 weeks of age with chronic mul-
           fer from recurrent severe infections. These often   tiple and severe viral/bacterial/fungal infections,
           involve the respiratory system, with atypical organ-  often respiratory or gastrointestinal. Affected
           isms (adenovirus,  Pneumocystis jiroveci, Escherichia   foals usually die by 2–6 months of age. Oral can-
           coli), within the first 2–3 months of life. The foals   didiasis is common and severe skin infections also
           usually die by 6–9 months of age of bacterial pneu-  occur.
           monia and/or enteritis.                          These foals have a severe non-regenerative anae-
                                                          mia, lymphopenia, low IgM levels and peripheral
           Differential diagnosis                         ganglionopathy. Diagnosis can be made via genetic
           Other immunodeficiences such as selective IgM   testing.
           deficiency; bacterial pneumonia.                 The prognosis is hopeless and euthanasia is
                                                          indicated once the diagnosis has been confirmed.
           Diagnosis                                      The genetic and, therefore, future breeding,
           Diagnosis is based on clinical signs, breed and age of   implications for the mare and stallion should be
           the foal. Once clinical signs become apparent there   considered.
           will be a persistent lymphopenia, absence of circulat-
           ing IgM (after maternally derived levels have waned)  IMMUNE-MEDIATED
           and lymphocytic hypoplasia of lymph nodes, spleen  THROMBOCYTOPENIA
           and thymus seen at biopsy or post-mortem exami-
           nation. Diagnosis is confirmed by genetic testing at   See Chapter 9, Haemolymphatic System (p. 1024);
           specialist laboratories.                       Fig. 14.3.
   1354   1355   1356   1357   1358   1359   1360   1361   1362   1363   1364